Related Experiment Video
Updated: Jul 15, 2026
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Postimplant dosimetry using a Monte Carlo dose calculation engine: a new clinical standard
Jean-François Carrier1, Michel D'Amours, Frank Verhaegen
1Département de Radio-Oncologie, et Centre de Recherche du CHUM, Hôpital Notre-Dame du CHUM, 1560 rue Sherbrooke Est, Montréal, Québec, Canada. jean-francois.carrier.chum@ssss.gouv.qc.ca
The Monte Carlo (MC) method offers a more accurate dose calculation for postimplant dosimetry than current clinical techniques. This advanced method accounts for interseed attenuation and tissue composition, leading to more precise dose delivery in prostate cancer treatment.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Dosimetry
Background:
- Current clinical dosimetry methods for brachytherapy may not fully account for complex physical interactions.
- Accurate dose calculation is crucial for effective treatment and minimizing side effects in prostate cancer radiotherapy.
Purpose of the Study:
- To evaluate the Monte Carlo (MC) method as a dose calculation engine for postimplant dosimetry.
- To compare MC results with clinical data in 28 patients, focusing on interseed attenuation and tissue composition effects.
Main Methods:
- Development of an automated MC program for dose distribution calculations.
- Calculation of dose distributions for the clinical target volume (CTV) and organs at risk (OARs).
- Specific MC techniques were employed to investigate interseed attenuation and tissue composition.
Main Results:
- The clinical technique systematically overestimates the dose in the CTV (mean difference 10.7 Gy) and OARs.
- Interseed attenuation (avg. 6.8 Gy) and tissue composition (avg. 4.1 Gy) significantly contribute to this overestimation.
- MC method demonstrated a more accurate dose deposition compared to the clinical approach.
Conclusions:
- The MC method provides a more accurate assessment of dose distribution in postimplant dosimetry.
- Clinical dosimetry overestimates dose, potentially impacting treatment efficacy and toxicity.
- MC method should be considered for establishing a new standard in clinical dosimetry and dose-outcome studies.
